TNF and inflammatory bowel disease: The established biological therapy in pediatric IBD has focused on the use of tumor necrosis factor (TNF) medications [4] Anti-TNF-α therapies are approved in induction and maintenance therapy for the treatment of moderate-to-severe pediatric IBD [5,6].